Position in IDYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,803,689
+$8,663,689 QoQ
Shares Held
370,370
+85.2% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#42
of 286 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. IDYA ranks #47 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,993,687 | $1,070,510,234 | |
| 2 | ARGX |
Argenx SE
|
709,446 | $658,202,715 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,746,415 | $631,875,071 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
5,061,175 | $620,398,831 | |
| 5 | CGON |
CG Oncology, Inc.
|
8,514,590 | $604,961,619 | |
| 6 | INSM |
INSMED Inc
|
4,842,880 | $516,347,865 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
13,900,620 | $434,533,381 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
4,251,996 | $377,492,204 |
All Filings in IDYA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,803,689 | 370,370 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $5,140,000 | 200,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,336,000 | 200,000 | Shares | Sole | 2024-11-14 | |
| 2021-12-31 | $59,574,596 | 2,520,076 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $83,256,839 | 3,266,255 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $68,558,692 | 3,266,255 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $57,956,992 | 2,466,255 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $25,855,802 | 1,846,843 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||